{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T16:33:52Z","timestamp":1780850032403,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.canlet.2008.01.046","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T18:14:17Z","timestamp":1208369657000},"page":"288-298","source":"Crossref","is-referenced-by-count":20,"title":["RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae"],"prefix":"10.1016","volume":"264","author":[{"given":"Apostolos","family":"Zaravinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bizakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios A.","family":"Spandidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.01.046_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002221503321046577","article-title":"Nasal polyps: still more questions than answers","volume":"117","author":"Bateman","year":"2003","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.canlet.2008.01.046_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1288\/00005537-199206000-00013","article-title":"The early stages of polyp formation","volume":"102","author":"Larsen","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canlet.2008.01.046_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00005537-199602000-00017","article-title":"Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages","volume":"106","author":"Norlander","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canlet.2008.01.046_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjc.6601488","article-title":"Conferring specificity on the ubiquitous Raf\/MEK signalling pathway","volume":"90","author":"O\u2019Neill","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2008.01.046_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/10457","article-title":"MEK wars, a new front in the battle against cancer","volume":"5","author":"Duesbery","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2008.01.046_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/rp.56.1.127","article-title":"Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade","volume":"56","author":"Avruch","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.01.046_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/43686","article-title":"Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP","volume":"401","author":"Yeung","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.01.046_bib9","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","article-title":"Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein","volume":"20","author":"Yeung","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.01.046_bib10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2174\/1381612043384420","article-title":"Targeting MAPK signalling: prometheus\u2019 fire or Pandora\u2019s box?","volume":"10","author":"Boldt","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.canlet.2008.01.046_bib11","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","article-title":"V599EB-RAF is an oncogene in melanocytes","volume":"64","author":"Wellbrock","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib12","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.febslet.2006.10.054","article-title":"Regulation of RKIP binding to the N-region of the Raf-1 kinase","volume":"580","author":"Park","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2008.01.046_bib13","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1038\/sj.onc.1208435","article-title":"RKIP downregulates B-Raf kinase activity in melanoma cancer cells","volume":"24","author":"Park","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.01.046_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/95.12.878","article-title":"Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis","volume":"95","author":"Fu","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2008.01.046_bib15","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-03-3861","article-title":"Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines","volume":"64","author":"Schuierer","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00016489709113422","article-title":"Assessment and staging of nasal polyposis","volume":"117","author":"Malm","year":"1997","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.canlet.2008.01.046_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)63154-7","article-title":"Joint Task Force summary statements on diagnosis and management of rhinitis","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.canlet.2008.01.046_bib18","first-page":"3362","article-title":"BRAF mutations in metastatic melanoma: a possible association with clinical outcome","volume":"9","author":"Kumar","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib19","first-page":"6451","article-title":"Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia","volume":"62","author":"Yuen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib20","first-page":"3955","article-title":"Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues","volume":"63","author":"Gorden","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib21","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1167\/iovs.02-1329","article-title":"Lack of BRAF mutation in primary uveal melanoma","volume":"44","author":"Cohen","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.canlet.2008.01.046_bib22","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.01.046_bib23","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib24","first-page":"7001","article-title":"Missense mutations of the BRAF gene in human lung adenocarcinoma","volume":"62","author":"Naoki","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib25","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma","volume":"62","author":"Brose","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.01.046_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.12.004","article-title":"Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas","volume":"209","author":"Nikiforova","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.01.046_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(03)00384-7","article-title":"BRAF and K-ras gene mutations in human pancreatic cancers","volume":"199","author":"Ishimura","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.01.046_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/418934a","article-title":"Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status","volume":"418","author":"Rajagopalan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.01.046_bib29","first-page":"1051","article-title":"Mutations and differential expression of the ras family genes in human nasal polyposis","volume":"31","author":"Zaravinos","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2008.01.046_bib30","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.01.046_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pros.20319","article-title":"Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer","volume":"66","author":"Fu","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2008.01.046_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2004.02.006","article-title":"Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene","volume":"207","author":"Keller","year":"2004","journal-title":"Cancer Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T02:24:34Z","timestamp":1546136674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0304383508000773"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.01.046","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}